Testosterone deficiency and replacement.

Area of Science:

• Endocrinology
• Andrology

Background:

• Testosterone is the primary male androgen, mainly produced by the testes.
• Testosterone deficiency (hypogonadism) causes numerous clinical issues including reduced bone density, altered body composition, and effects on mood, cognition, and cardiovascular risk.
• Androgen replacement therapy is beneficial for overt hypogonadism, improving bone/muscle mass, reducing fat, and enhancing quality of life.

Purpose of the Study:

• To examine the impact of male hypogonadism and the response to androgen replacement therapy.
• To address the question of patient selection for therapy, particularly in mild hypogonadism and elderly men.
• To provide an overview of available androgen replacement therapy options.

Main Methods:

• Review of existing evidence on male hypogonadism and androgen therapy.
• Discussion of clinical effects and benefits of testosterone replacement.
• Analysis of different modes of androgen delivery (oral, intramuscular, subcutaneous, transdermal).

Main Results:

• Androgen replacement therapy is clearly beneficial in overt hypogonadism.
• Benefits in milder forms of hypogonadism and in elderly men with physiological testosterone deficiency are less defined.
• Various delivery methods exist, each with pros and cons, influencing patient choice.

Conclusions:

• The optimal biochemical threshold for initiating testosterone replacement therapy remains undefined.
• Newer formulations like long-acting intramuscular injections and testosterone gels offer improved delivery and patient experience.
• Careful consideration of individual patient needs and specific hypogonadism context is crucial for effective androgen replacement therapy.